Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Glypromate in patients undergoing cardiopulmonary bypass surgery
ISRCTN47685900Phase 3Completed
- Sponsor
- Neuren Pharmaceuticals Limited
- Start
- Jun 2007
- Modality
- Small Molecules, Peptides
01
Overview
Phase 3, randomised, double-blind trial in post-operative cognitive decline (POCD) and Functional impairment after cardiopulmonary bypass surgery comparing Glypromate with Placebo (2 arms). Primary endpoints: Composite cognitive Z score and Composite activities of daily living score. Started Jun 2007; status: completed.
02
Drugs
glypromate
03
Conditions
post-operative cognitive decline (POCD)Functional impairment after cardiopulmonary bypass surgery
Beyond the preview
Go deeper on ISRCTN47685900.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN47685900.